--
Related Articles
Research
Research Alert: Regn Posts Strong Q1 Fueled By Dupixent And Eylea Hd Amid Manufacturing Issues
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Regeneron delivered robust Q1 2026 results with total revenues of $3.6B (+19% Y/Y) and non-GAAP EPS of $9.47 (+15% Y/Y), beating consensus estimates. The EYLEA franchise continues to transition from traditional EYLEA to EYLEA HD, with HD sales reaching $468M (+52% Y/Y) while traditional sales declined to $473M (-36% Y/Y) due to biosimilar competition. We view the underlying portfolio strength as encouraging, with Dupixent maintaining exceptional momentum at global sales of $4.9B (+33% Y/Y) and physician unit demand for EYLEA HD increasing 10% sequentially despite inventory normalization. Management expects manufacturing disruptions at the Limerick facility to normalize by the end of Q2, lowering full-year GAAP gross margin guidance to 77%-78%. We believe the company's diversified revenue base and deep pipeline of nearly 50 clinical programs, including the recent Otarmeni approval and advancing Factor XI antibody Phase 3 studies, position REGN well for continued growth despite near-term manufacturing headwinds.
$REGN
Asia
Rita Finance and Leasing Names CFO
Rita Finance and Leasing (BOM:543256, NSE:RFLL) appointed Mukesh Laxman Sharma as chief financial officer of the company, effective Wednesday, according to a same-day filing on Indian bourses.
$BOM:543256$NSE:RFLL
Asia
Sterlite Technologies Returns to Profit in Fiscal Q4
Sterlite Technologies (NSE:STLTECH, BOM:532374) returned to attributable consolidated net profit of 590 million Indian rupees in the fiscal fourth quarter ended March 31, from a loss of 400 million rupees a year ago.Earnings per share stood at 1.17 rupees compared with a loss per share of 0.84 rupees, according to a Wednesday filing by the optic fiber cables manufacturer to the stock exchanges.Revenue from operations in fiscal Q4 increased to 14.4 billion rupees from 10.5 billion rupees a year earlier.
$BOM:532374$NSE:STLTECH